Litcius/Paper detail

Risk of pneumonitis in non-small cell lung cancer patients with preexisting interstitial lung diseases treated with immune checkpoint inhibitors: a nationwide retrospective cohort study

Kenji Sawa, Izumi Sato, Masato Takeuchi, Koji Kawakami

2022Cancer Immunology Immunotherapy14 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePneumonitisLung cancerInternal medicineCumulative incidenceRetrospective cohort studyHazard ratioChemotherapyIncidence (geometry)CohortOncologyLungConfidence intervalOpticsPhysicsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisCancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Risk of pneumonitis in non-small cell lung cancer patients with preexisting interstitial lung diseases treated with immune checkpoint inhibitors: a nationwide retrospective cohort study | Litcius